Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ITPRIPL2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | PPM1E | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | OGFOD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | NCF4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | SVIP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | DOCK11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ACOT9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | EIF5A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | IRAK1BP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ALMS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |